Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary A Markiewicz

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Plos One|October 22, 2014
Role of NKG2D in obesity-induced adipose tissue inflammation and insulin resistanceJun-Jae Chung, Mary A Markiewicz, Bojan Polić, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 13, 2017
NKG2D Signaling between Human NK Cells Enhances TACE-Mediated TNF-α ReleaseNeekun Sharma, Camille V Trinidad, Andrew P Trembath, et al.
Frontiers in Immunology|November 18, 2021
Editorial: The Role of Natural Killer Cells in Autoimmune DiseasesAlessandra Fierabracci, Domenico V Delfino, Mary A Markiewicz, et al.
Immunohorizons|March 3, 2018
A Protective Role for NKG2D-H60a Interaction via Homotypic T Cell Contact in Nonobese Diabetic Autoimmune Diabetes PathogenesisAndrew P Trembath, Neekun Sharma, Saravanan Raju, et al.
International Reviews of Immunology|September 10, 2003
CD4+ T cell matters in tumor immunityMarkwin P Velders, Mary A Markiewicz, Gretchen L Eiben, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
ICAM-1 contributes to but is not essential for tumor antigen cross-priming and CD8+ T cell-mediated tumor rejection in vivoChristian Blank, Ian Brown, Aalok K Kacha, et al.
European Journal of Immunology|September 25, 2010
Kinase suppressor of Ras 1 is required for full ERK activation in thymocytes but not for thymocyte selectionErin L Filbert, Anhco Nguyen, Mary A Markiewicz, et al.
Diabetes|June 15, 2020
NKG2D Signaling Within the Pancreatic Islets Reduces NOD Diabetes and Increases Protective Central Memory CD8<sup>+</sup> T-Cell NumbersAndrew P Trembath, Kelsey L Krausz, Neekun Sharma, et al.
Diabetes|July 10, 2021
Erratum. NKG2D Signaling Within the Pancreatic Islets Reduces NOD Diabetes and Increases Protective Central Memory CD8<sup>+</sup> T-Cell Numbers. Diabetes 2020;69:1749-1762Andrew P Trembath, Kelsey L Krausz, Neekun Sharma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 2025
NKG2D ligand expression on NK cells induces NKG2D-mediated cross-tolerization of cytokine signaling and reduces NK cell tumor immunityZoe K Bedrosian, Elizabeth M Ruark, Neekun Sharma, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Plos One|October 22, 2014
Role of NKG2D in obesity-induced adipose tissue inflammation and insulin resistanceJun-Jae Chung, Mary A Markiewicz, Bojan Polić, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 13, 2017
NKG2D Signaling between Human NK Cells Enhances TACE-Mediated TNF-α ReleaseNeekun Sharma, Camille V Trinidad, Andrew P Trembath, et al.
Frontiers in Immunology|November 18, 2021
Editorial: The Role of Natural Killer Cells in Autoimmune DiseasesAlessandra Fierabracci, Domenico V Delfino, Mary A Markiewicz, et al.
Immunohorizons|March 3, 2018
A Protective Role for NKG2D-H60a Interaction via Homotypic T Cell Contact in Nonobese Diabetic Autoimmune Diabetes PathogenesisAndrew P Trembath, Neekun Sharma, Saravanan Raju, et al.
International Reviews of Immunology|September 10, 2003
CD4+ T cell matters in tumor immunityMarkwin P Velders, Mary A Markiewicz, Gretchen L Eiben, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
ICAM-1 contributes to but is not essential for tumor antigen cross-priming and CD8+ T cell-mediated tumor rejection in vivoChristian Blank, Ian Brown, Aalok K Kacha, et al.
European Journal of Immunology|September 25, 2010
Kinase suppressor of Ras 1 is required for full ERK activation in thymocytes but not for thymocyte selectionErin L Filbert, Anhco Nguyen, Mary A Markiewicz, et al.
Diabetes|June 15, 2020
NKG2D Signaling Within the Pancreatic Islets Reduces NOD Diabetes and Increases Protective Central Memory CD8<sup>+</sup> T-Cell NumbersAndrew P Trembath, Kelsey L Krausz, Neekun Sharma, et al.
Diabetes|July 10, 2021
Erratum. NKG2D Signaling Within the Pancreatic Islets Reduces NOD Diabetes and Increases Protective Central Memory CD8<sup>+</sup> T-Cell Numbers. Diabetes 2020;69:1749-1762Andrew P Trembath, Kelsey L Krausz, Neekun Sharma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 2025
NKG2D ligand expression on NK cells induces NKG2D-mediated cross-tolerization of cytokine signaling and reduces NK cell tumor immunityZoe K Bedrosian, Elizabeth M Ruark, Neekun Sharma, et al.
Pageof 4